Clinical Trials in California

Showing 7141-7160 of 8,631 trials

Study of Oasis Ultra in Diabetic Foot Ulcers

NCT01835379

Many people with diabetes will develop a non-healing diabetic foot ulcer. Many ways are available to try to get a diabetic foot ulcer to heal, including application of Oasis Ultra. The hypothesis to be tested is that application of Oasis Ultra will cause more diabetic foot ulcers to heal than wounds treated with regular medical care. Subjects will have their diabetic foot wounds treated for up to 12 weeks with Oasis Ultra or regular medical care .

Diabetic Foot Ulcer

Healthpoint82 participantsStarted May 2013

Little Rock, Arkansas, United States • Carlsbad, California, United States • Fair Oaks, California, United States +13 more locations

COMPLETEDPhase 262 miles

hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

NCT00082758

RATIONALE: Biological therapies such as hu14.18-interleukin-2 fusion protein work in different ways to stimulate the immune system and stop tumor cells from growing. PURPOSE: This phase II trial is studying how well hu14.18-interleukin-2 fusion protein works in treating young patients with recurrent or refractory neuroblastoma.

Neuroblastoma

Children's Oncology Group39 participantsStarted Aug 2005

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +78 more locations

Study of Oasis Ultra in Diabetic Foot Ulcers

hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Find Trials by Condition in California

A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer

Aneurysm Study of Pipeline in an Observational Registry

Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

NAVISTAR® THERMOCOOL® SF Catheter: Observational Study

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Cognitive Rehabilitation of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans With Cognitive Disorder

Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women

Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency